NECTA Dangerous Ideas in Drug Development - Etira
Update: 2024-05-22
Description
In our latest episode we're joined by Etira, a company exploring a novel mechanism of inducing targeted ER stress in cancer. Learn with us about how LIPA is targeted to generate anticancer effects with prospects across many cancers.
Comments
In Channel